MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

8.280 UNCHANGED
Last Price Updated: 8:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.280
Bid (Size) 8.310 (300)
Ask (Size) 8.500 (100)
Prev. Close 8.280
Today's Range 8.280 - 8.280
52wk Range 4.810 - 10.59
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
From Helus Pharma
Via Business Wire
News headline image
Cybin Initiates At-The-Market Equity Program of up to US$100 Million
From Cybin Inc.
Via Business Wire

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
+30.4%
+30.4%
6 Month
+8.5%
+8.5%
1 Year
-11.6%
-11.6%

More News

Read More
News headline image
Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
From Cybin Inc.
Via Business Wire
News headline image
Earnings Scheduled For November 13, 2025 ↗
Via Benzinga
News headline image
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
Via Stocktwits
Topics Cannabis ETFs Government
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN)Announces Transfer of U.S. Listing to Nasdaq and Ticker Change to HELP
Via Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Reports Q2 2025 Results and Advances Late-Stage Neuropsychiatry Programs
Via Investor Brand Network
Topics Intellectual Property
News headline image
Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) to Present at Jefferies Global Healthcare Conference in London
Via Investor Brand Network
News headline image
What's Next: Cybin's Earnings Preview ↗
Via Benzinga
News headline image
Cybin to Participate in the Jefferies Global Healthcare Conference in London
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sets Nov. 13 Call to Review Q2 Results and Business Update
Via Investor Brand Network
News headline image
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) to Participate in Guggenheim 2nd Annual Healthcare Innovation Conference
Via Investor Brand Network
News headline image
Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Chief Medical Officer to Speak at 2025 Milken Institute Future of Health Summit
Via Investor Brand Network
News headline image
Cybin to Participate at the 2025 Milken Institute Future of Health Summit
From Cybin Inc.
Via Business Wire
News headline image
Cybin Announces Closing of $175 Million Registered Direct Offering
From Cybin Inc.
Via Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Closes US$175 Million Registered Direct Offering Led by Top Healthcare Investors
Via Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces US$175M Registered Direct Offering With Warrants Priced at US$6.51
Via Investor Brand Network
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Cybin Announces $175 Million Registered Direct Offering
From Cybin Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cybin Inc. - CYBN
From Pomerantz LLP
Via GlobeNewswire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Highlights Clinical and Regulatory Milestones, Prepares for Upcoming Catalysts
Via Investor Brand Network
Topics Intellectual Property
News headline image
Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones
From Cybin Inc.
Via Business Wire

Frequently Asked Questions

Is Cybin Inc. Common Shares publicly traded?
Yes, Cybin Inc. Common Shares is publicly traded.
What exchange does Cybin Inc. Common Shares trade on?
Cybin Inc. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Cybin Inc. Common Shares?
The ticker symbol for Cybin Inc. Common Shares is CYBN on the New York Stock Exchange
What is the current price of Cybin Inc. Common Shares?
The current price of Cybin Inc. Common Shares is 8.280
When was Cybin Inc. Common Shares last traded?
The last trade of Cybin Inc. Common Shares was at 01/02/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story